A Thirty‐Year Odyssey in Nitrogen Metabolism: From Ammonium to Dipeptides
2000; Wiley; Volume: 24; Issue: 4 Linguagem: Inglês
10.1177/0148607100024004197
ISSN1941-2444
Autores Tópico(s)Metabolism and Genetic Disorders
ResumoJournal of Parenteral and Enteral NutritionVolume 24, Issue 4 p. 197-209 Lecture A Thirty-Year Odyssey in Nitrogen Metabolism: From Ammonium to Dipeptides Peter Fürst MD, PhD, Peter Fürst MD, PhD University of Hohenheim, D-Stuttgart/GermanySearch for more papers by this author Peter Fürst MD, PhD, Peter Fürst MD, PhD University of Hohenheim, D-Stuttgart/GermanySearch for more papers by this author First published: 01 July 2000 https://doi.org/10.1177/0148607100024004197Citations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1Rombeau JL, Muldoon D.: Jonathan E. Rhoads M. D.-Quaker Sense and Sensibility in the World of Surgery. Hanley & Belfus, Inc., Philadelphia, 1997 2Rhoads JE, Stengel A. Jr, Riegel C., et al: The absorption of protein split products from chronic isolated colon loops. Am J Physiol 125: 707– 712, 1939 3Adams A.: Address: Rhoads pavilion dedication. Philadelphia, PA, 1994 4Lusk G.: The Science of Nutrition. Saunders, Philadelphia, PA, 1928, p 145 5Szám I.: Introduction. IN Ammonia Metabolism, Szám I (ed). Schattauer, Stuttgart, 1972, pp 3– 5 6Fürst P., Josephson B., Maschio G., et al: Nitrogen balance after intravenous and oral administration of ammonium salts to man. J Appl Physiol 26: 13– 22, 1969 7Fürst P., Jonsson A., Josephson B., et al: Distribution in muscle and liver vein protein of 15N administered as ammonium acetate to man. J Appl Physiol 29: 307– 312, 1970 8Fürst P., Bergström J., Josephson B., et al: The effect of dialysis and administration of essential amino acids on plasma and muscle protein synthesis studied with 15N in uremic patients. Proc Eur Dial Transplant Assoc 6: 175– 181, 1970 9Fürst P.: 15N studies in severe renal failure. I. Influence of amino acid administration on nitrogen balance. Scand J Clin Lab Invest 29: 359– 367, 1972 10Richards P., Metcalfe-Gibson A., Ward EE, et al: Utilisation of ammonia nitrogen for protein synthesis in man, and the effect of protein restriction and uraemia. Lancet 2: 845– 849, 1967 11Giordano C., De PC, Balestrieri C., et al: Incorporation of urea 15N in amino acids of patients with chronic renal failure on low nitrogen diet. Am J Clin Nutr 21: 394– 404, 1968 12Fürst P., Jonsson A.: Control and modification of methods for determination of 15N in biological material. Acta Chem Scand 25: 930– 938, 1971 13Fürst P.: 15N-studies in severe renal failure. II. Evidence for the essentiality of histidine. Scand J Clin Lab Invest 30: 307– 312, 1972 14Vinnars E., Fürst P., Josephson B.: Einwirkung des Verhältnisses zwischen essentiellen und nicht-essentiellen Aminosäuren auf die Stickstoff-Retention bei Gesunden. IN Anaesthesiologie und Wiederbelebung, Anonymous. Springer Verlag, Berlin, 1972, pp 9– 10 15Elliott DF, Neuberger A.: The irreversibility of the deamination of threonine in the rabbit and rat. Biochem J 46: 207– 210, 1950 16Alvestrand A., Ahlberg M., Bergström J., et al: Clinical results of long term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia. Clin Nephrol 19: 67– 73, 1983 17Fürst P.: Amino acid metabolism in uremia. J Am Coll Nutr 8: 310– 323, 1989 18Bergström J. : Amino acid abnormalities in renal failure. IN Nutrition and the Origin of Disease, Halstead C, Rucker R (eds). Academic Press, New York, 185– 198, 1989 19Walser M., Lund P., Ruderman NB, et al: Synthesis of essential amino acids from their alpha-keto analogues by perfused rat liver and muscle. J Clin Invest 52: 2865– 2877, 1973 20Richards P.: The metabolism and clinical relevance of the keto acid analogues of essential amino acids. Clin Sci Mol Med 54: 589– 593, 1978 21Giordano C., Phillips ME, De SN, et al: Utilisation of ketoacid analogues of valine and phenylalanine in health and uraemia. Lancet 1: 178– 182, 1972 22Halliday D., Madigan M., Chalmers RA, et al: The degree of conversion of alpha-keto acids to valine and phenylalanine in health and uraemia. Q J Med 50: 53– 62, 1981 23Kedenburg C-P. : A lithium buffer system for accelerated single-column amino acid analysis in physiological fluids. Anal. Biochem. 40: 35– 42, 1971 24Bergström J., Fürst P., Noree L-O., et al: The effect of peritoneal dialysis on the intracellular free amino acids in muscle from uremic patients. Proc Eur Dial Transplant Assoc 9: 393– 401, 1972 25Bergström J., Fürst P., Noree L-O., et al: Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36: 693– 697, 1974 26Vinnars E., Bergström J., Fürst P.: Influence of the postoperative state on the intracellular free amino acids in human muscle tissue. Ann Surg 182: 665– 671, 1975 27Graser TA, Godel HG, Albers S., et al: An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids. Anal Biochem 151: 142– 152, 1985 28Fürst P.: Intracellular muscle free amino acids: Their measurement and function. Proc Nutr Soc 42: 451– 462, 1983 29Fürst P., Stehle P.: Are intravenous amino acid solutions unbalanced ? New Horizons 2: 215– 223, 1994 30Wretlind A. : Parenteral nutrition. Nutr Rev 39: 257– 265, 1981 31Wilmore DW: The practice of clinical nutrition: How to prepare for the future. JPEN 13: 337– 343, 1989 32Fürst P.: Old and new substrates in clinical nutrition. J Nutr 128: 789– 796, 1998 33Annan GL: An exhibition of books on the growth of our knowledge of blood transfusion. Bull NY Acad Med 15: 622– 632, 1939 34Abderhalden E., Rona P.: Fütterungsversuche mit durch Pankreatin, durch Pepsinsalzsäure plus Pankreatin und durch Säure hydrolysiertem Casein. Hoppe-Seyler's Z Physiol Chem 42: 528– 539, 1904 35Friedrich PL : Die künstliche subkutane Ernährung in der praktischen Chirugie Arch Klin Chir 73: 507– 516, 1904 36Henriques V., Andersen AC: Über parenterale Ernährung durch intravenöse Injektion. Hoppe-Seyler's Z Physiol Chem 88 : 357– 369, 1913 37Elman R.: Amino acid content of the blood following intravenous injection of hydrolyzed casein. Proc Soc Exp Biol Med 37 : 437– 440, 1937 38Wretlind A. : Free amino acids in dialyzed casein digest. Acta Physiol Scand 13: 45– 54, 1945 39Wretlind A. : The amino acid content of a dialysed enzymatic casein hydrolysate. Acta Physiol Scand 27: 189– 203, 1952 40Agar WT, Hird FJR, Sidhu GS: The active absorption of amino acids by the intestine. J Physiol 145: 255– 263, 1953 41Wiggans DS, Johnston JM: The absorption of peptides. Biochim Biophys Acta 32: 69– 73, 1959 42Newey H., Smyth DH: The intestinal absorption of some dipeptides. J Physiol 145: 48– 56, 1959 43Matthews DM, Craft IL, Geddes DM, et al: Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci 35: 415– 424, 1968 44Adibi SA, Phillips E.: Evidence for greater absorption of amino acid from peptide than from free form by human intestine. Clin Res 16: 446, 1968 45Matthews DM : Intestinal absorption of peptides. Physiol Rev 55: 535– 608, 1975 46Das M., Radhakrishnan AN: Role of peptidases and peptide transport in the intestinal absorption of proteins. World Rev Nutr Diet 24: 58– 87, 1976 47Das M., Radhakrishnan AN: Glycyl-L-leucin hydrolase, a versatile ‘master’ dipeptidase from monkey small intestine. Biochem J 135: 609– 615, 1973 48Stehle P., Kühne B., Kubin W., et al: Synthesis and characterization of tyrosine- and glutamine-containing peptides. J Appl Biochem 4: 280– 286, 1982 49Konopinska D., Muzalewski F.: Proteolytic enzymes in peptide synthesis. Mol Cell Biochem 51: 165– 175. 1983 50Jakubke H-D., Kuhl P., Könnecke A.: Basic principles ofproteasecatalyzed peptide bond formation. Angew Chem Int Ed 24: 85- 93, 1985 51Stehle P., Bahsitta H-P., Monter B. et al: Papain-catalyzed synthesis of dipeptides. A novel approach using free amino acids as nucleophiles. Enzyme Microb Technol 12: 56– 60, 1990 52Monter B., Herzog B., Stehle P. et al: Kinetically controlled synthesis of dipeptides using ficin as biocatalyst. Biotechnol Appl Biochem 14: 183– 191, 1991 53Stehle P., Bahsitta H-P., Fürst P.: Analytical control of enzyme-catalyzed peptide synthesis using capillary isotachophoresis. J Chromatogr 370: 131– 138, 1986 54Fürst P., Pogan K., Hummel M., et al: Reappraisal of indispensable amino acids. Design of parenteral synthetic dipeptides for clinical nutrition: Synthesis and characterization. Ann Nutr Metab 41: 1– 9, 1997 55Behal FJ, Hamilton RD, Dawson FB, et al: A study of the activity of human plasma aminopeptidase components on dipeptides and chromogenic substrates. Arch Biochem Biophys 108: 207– 214, 1964 56Krzysik BA, Adibi SA: Cytoplasmic dipeptidase activities of kidney, ileum, jejunum, liver, muscle, and blood. Am J Physiol 233: E450– 456, 1977 57Adibi SA, Paleos GA, Morse EL: Influence of molecular structure on half-life and hydrolysis of dipeptides in plasma: Importance of glycine as N-terminal amino acid residue. Metabolism 35: 830– 836, 1986 58Herzog B., Frey B., Pogan K., et al: In vitro peptidase activity of rat mucosa cell fractions against glutamine-containing dipeptides. J Nutr Biochem 7: 135– 141, 1996 59Abumrad NN, Morse EL, Lochs H., et al: Possible sources of glutamine for parenteral nutrition: Impact on glutamine metabolism. Am J Physiol 257: E228– 234, 1989 60Stehle P., Fürst P.: In vitro hydrolysis of glutamine-, tyrosine-and cystine-containing short chain peptides. Clin Nutr 9: 37– 38, 1990 61Hummel M., Pogan K., Stehle P., et al: Intestinal taurine availability from synthetic amino acid-taurine conjugates: An in vitro perfusion study in rats. Clin Nutr 16: 137– 139, 1997 62Fürst P., Pogan K., Hummel M., et al: Design of parenteral synthetic dipeptides for clinical nutrition: In vitro and in vivo utilization. Ann Nutr Metab 41: 10– 21, 1997 63Adibi SA, Krzysik BA, Drash AL: Metabolism of intravenously administered dipeptides in rats: Effects on amino acid pools, glucose concentration and insulin and glucagon secretion. Clin Sci Mol Med 52: 193– 204, 1977 64Adibi SA, Krzysik BA: Effect of nephrectomy and enterectomy on plasma clearance of intravenously administered dipeptides in rats. Clin Sci Mol Med 52: 205– 213, 1977 65Adibi SA, Morse EL: Enrichment of glycine pool in plasma and tissues by glycine, di-, tri-, and tetraglycine. Am J Physiol 243: E413– 417, 1982 66Daabees TT, Stegink LD: L-Alanyl-L-tyrosine as a tyrosine source during intravenous nutrition of the rat. J Nutr 108: 1104– 1113, 1978 67Stehle P., Albers S., Pollack L., et al: In vivo utilization of cystine-containing synthetic short chain peptides after intravenous bolus injection in the rat. J Nutr 118: 1470– 1474, 1988 68Kee AJ, Smith RC, Gross AS, et al: The effect of dipeptide structure on dipeptide and amino acid clearance in rats. Metabolism 43: 1373– 1378, 1994 69Neuhäuser M., Wandira JA, Göttmann U., et al: Utilization of N-acetyl-L-tyrosine and glycyl-L-tyrosine during long-term parenteral nutrition in the growing rat. Am J Clin Nutr 42: 585- 596, 1985 70Fürst P., Kuhn KS, Stehle P.: New nitrogen-containing substrates in artificial nutrition. IN From Nutritional Support to Pharmacologic Nutrition in the ICU, Kudsk KA., Pichard C (eds). Springer, Heidelberg. 2000. pp 449– 460 71Stehle P., Weber S., Fürst P.: Parenteral glycyl-L-tyrosine maintains tyrosine pools and supports growth and nitrogen balance in phenylalanine-deficient rats. J Nutr 126: 663– 667, 1996 72Hilton MA, Hilton FK, Montgomery W., et al: Use of the stable peptide. gamma-L-glutamyl-L-tyrosine, as an intravenous source of tyrosine in mice. Metabolism 40: 634– 638, 1991 73Radmacher PG, Hilton MA, Hilton FK, et al: Use of the soluble peptide 7-L-glutamyl-L-tyrosine to provide tyrosine in total parenteral nutrition (TPN) in rats. JPEN 17: 337– 344, 1993 74Berger DC, Hilton MA, Hilton FK, et al: Intravenous gamma-glutamyl-tyrosine elevates brain tyrosine but not catecholamine concentrations in normal rats. Metabolism 45: 126– 132, 1996 75Jiang Z.-M., Wang L.-J., Qi Y., et al: Comparison of parenteral nutrition supplemented with L-glutamine or glutamine dipeptides. JPEN 17: 134– 141, 1993 76Lochs H., Williams PE, Morse EL, et al: Metabolism of dipeptides and their constituent amino acids by liver, gut, kidney, and muscle. Am J Physiol 254: E588– 594, 1988 77Stehle P., Ratz I., Fürst P.: Whole-body autoradiography in the rat after intravenous bolus injection of L-alanyl-L-[U-14 C]glutamine. Ann Nutr Metab 35: 213– 220, 1991 78Babst R., Hörig H., Stehle P., et al: Glutamine peptide-supplemented long-term TPN: Effects on intracellular and extracellular amino acid patterns, nitrogen economy, and tissue morphology in growing rats. JPEN 17: 566– 574, 1993 79Karner J., Roth E., Ollenschläger G., et al: Glutamine-containing dipeptides as infusion substrates in the septic state. Surgery 106: 893– 900, 1989 80Roth E., Karner J., Ollenschldger G., et al: Alanylglutamine reduces muscle loss of alanine and glutamine in postoperative anaesthetized dogs. Clin Sci 75: 641– 648, 1988 81Borel MJ, Williams PE, Jabbour K., et al: Chronic hypocaloric parenteral nutrition containing glutamine promotes hepatic rather than skeletal muscle or gut uptake of glutamine after fasting. JPEN 20: 25– 30, 1996 82Bai M-J., Jiang Z-M., Liu Y-W., et al: Effects of alanyl-glutamine on gut barrier function. Nutrition 12: 793– 796, 1996 83Liu PT, Ionnides C., Symons AM, et al: Role of tissue glutathione in prevention of surgical trauma. Xenobiotica 23: 899– 911, 1993 84Naka S., Saito H., Hashiguchi Y., et al: Alanyl-glutamine-supplemented TPN improves survival and protein metabolism in rat protracted peritonitis model. JPEN 20: 417– 423, 1996 85Schröder J., Wardelmann E., Winkler W., et al: Glutamine dipeptide-supplemented parenteral nutrition reverses gut atrophy, disaccharidase enzyme activity, and absorption in rats. JPEN 19: 502– 506, 1995 86Tamada H., Nezu R., Imamura I., et al: The dipeptide alanylglutamine prevents intestinal mucosal atrophy in parenterally fed rats. JPEN 16: 110– 116, 1992 87Tamada H., Nezu R., Matsuo Y., et al: Alanyl glutamine-enriched TPN restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN 17: 236– 242, 1993 88Scheppach W., Dusel G., Kuhn T., et al: Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury. Gut 38: 878– 885, 1996 89Li YS, Li JS, Jiang JW, et al: Glycyl-glutamine-enriched long-term TPN attenuates bacterial translocation following small bowel transplantation in the pig. J Surg Res 82: 106– 111, 1999 90Wischmeyer PE, Musch MW, Madonna MB, et al: Glutamine protects intestinal epithelial cells: Role of inducible HSP70. Am J Physiol 272: G879– 884, 1997 91Li J., Kudsk KA, Janu P. et al: Effect of glutamine-enriched TPN on small intestinal gut-associated lymphoid tissue and upper respiratory tract immunity. Surgery 121: 542– 549. 1997 92Li J., King BK, Janu PG et al: Glycyl-L-glutamine-enriched TPN maintains small intestine gut-associated lymphoid tissue and upper respiratory tract immunity. JPEN 22: 31– 36. 1998 93Yu JC, Jiang ZM, Li DM et al: Alanyl-glutamine preserves hepatic glutathione stores after 5-FU treatment. Clin Nutr 15: 261– 265. 1996 94Harward TR, Coe D., Souba WW et al: Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res 56: 351– 355, 1994 95Hong RW, Rounds JD, Helton WS et al: Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215: 114- 119, 1992 96Albers S., Wernerman J., Stehle P., et al: Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides : Kinetic evaluation of L-alanyl-L-glutamine and glycyl-L-tyrosine. Clin Sci 75: 463– 468, 1988 97Druml W., Lochs H., Roth E., et al: Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol 260: E280– 285, 1991 98Albers S., Wernerman J., Stehle P., et al: Availability of amino acids supplied by constant intravenous infusion of synthetic dipeptides in healthy man. Clin Sci 76: 643– 648, 1989 99Lochs H., Hübl W., Gasic S., et al: Glycylglutamine: Metabolism and effects on organ balances of amino acids in postabsorptive and starved subjects. Am J Physiol 262: E155– 160, 1992 100Lochs H., Roth E., Gasic S., et al: Splanchnic, renal, and muscle clearance of alanylglutamine in man and organ fluxes of alanine and glutamine when infused in free and peptide forms. Metabolism 39: 833– 836, 1990 101Druml W.: Nutritional considerations in the treatment of acute renal failure in septic patients. Nephrol Dial Transplant 9: S219– 223, 1994 102Stehle P., Zander J., Mertes N., et al: Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet i: 231– 233, 1989 103Druml W., Hübl W., Roth E., et al: Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure. Hepatology 21: 923– 928, 1995 104Fürst P.: The role of antioxidants in nutritional support. Proc Nutr Soc 55: 945– 961, 1996 105Grimble RF : Nutritional antioxidants and the modulation of inflammation: Theory and practice. New Horizons 2: 175– 185, 1994 106Fürst P., Stehle P.: Parenteral nutrition substrates. IN Artificial Nutrition Support in Clinical Practice, Payne-James J, Grimble G, Silk D (eds). Edward Arnold, London, 1995, pp 301– 322 107Fürst P., Albers S., Stehle P., et al: Parenteral use of L-alanyl-L-glutamine (Ala-Gln) and glycyl-L-tyrosine (Gly-Tyr) in postoperative patients. Clin Nutr 7: S41, 1988 108Jacobi CA, Ordeman J., Zuckermann H., et al: The influence of Alanyl-Glutamine in postoperative TPN on immune functions and morbidity: Preliminary results of a prospective randomized trial. Langenbecks Arch Chir 1998: 605– 611, 1998 109Morlion BJ, Köller M., Wachtler P., et al: Influence of L-alanyl-L-glutamine (ala-gln) dipeptide on the synthesis of leukotrienes and cytokines in vitro. 4th International Congress on The Immune Consequences of Trauma, Shock and Sepsis, 1997, pp 269–272 110deBeaux AC, O'Riordain MG, Ross JA, et al: Glutamine-supplemented TPN reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition 14: 261– 265, 1998 111Morlion BJ, Stehle P., Wachtler P., et al: TPN with glutamine dipeptide after major abdominal surgery: A randomized, double-blind, controlled study. Ann Surg 227: 302– 308, 1998 112Morlion BJ, Torwesten E., Kuhn KS, et al: Cysteinyl-leucotriene generation as a biomarker for survival in the critically ill. Crit Care Med (in press) 113Häussinger D., Roth E., Lang F., et al: Cellular hydration state: An important determinant of protein catabolism in health and disease. Lancet 341: 1330– 1332, 1993 114Borel MJ, Williams PE, Jabbour K., et al: Parenteral glutamine infusion alters insulin-mediated glucose metabolism. JPEN 22: 280– 285, 1998 115Ballard TC, Farag A., Branum GD, et al: Effect of L-glutamine supplementation on impaired glucose regulation during intravenous lipid administration. Nutrition 12: 349– 354, 1996 116Khogali SE, Harper AA, Lyall JA, et al: Effects of L-glutamine on post-ischaemic cardiac function: Protection and rescue. J Mol Cell Cardiol 30: 819– 827, 1998 117Stehle P., Ratz I., Fürst P.: In vivo utilization of intravenously supplied L-alanyl-L-glutamine in various tissues of the rat. Nutrition 5: 411– 415, 1989 118Liu YW, Bai MX, Ma YX et al: Effects of alanyl-glutamine on intestinal adaptation and bacterial translocation in rats after 60% intestinal resection. Clin Nutr 16: 75– 78, 1997 119Hammarqvist F., Wernerman J., Von der Decken A., et al: Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg 212: 637– 644. 1990 120Karner J., Roth E., Stehle P., et al: Influence of glutamine-containing dipeptides on muscle amino acid metabolism. IN Nutrition in Clinical Practice, Hartig W, Dietze G, Weiner R, et al (eds). Karger, Basel, 1989, pp 56– 70 121Fürst P., Albers S., Stehle P.: Glutamine-containing dipeptides in parenteral nutrition. JPEN 14: 118S– 124S, 1990 122Jiang ZM, Cao JD, Zhu XG, et al: The impact of glutamine dipeptide on nitrogen balance, intestinal permeability and clinical outcome of post operative patients. JPEN 23: S52– 58, 1999 123Fürst P.: Effects of supplemental parenteral L-aLanyl-L-glutamine (ALA-GLN) following elective operation: A European multicenter study. Clin Nutr (in press) 124Petersson B., Waller S-O., Von der Decken A., et al: The long-term effect of postoperative TPN supplemented with glycylglutamine on protein synthesis in skeletal muscle. Clin Nutr 10(special suppl 2): 10, 1991 125Barua JM, Wilson E., Downie S., et al: The effect of alanylglutamine peptide supplementation on muscle protein synthesis in post-surgical patients receiving glutamine-free amino acids intravenously. Proc Nutr Soc 51: 104A. 1992 126Van der Hulst Rrwj., Van Kreel BK, Von Meyenfeldt MF et al: Glutamine and the preservation of gut integrity. Lancet 341: 1363– 1365, 1993 127Decker-Baumann C., Frohmüller S. v., Herbay A., et al: Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metatstatic colorectal cancer. Eur J Cancer 35: 202– 207, 1999 128van Zaanen HCT, van der Lelie J., Timmer JG, et al: Parenteral glutamine supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 74: 2879– 2884, 1994 129Brown SA, Goringe A., Fegan C., et al: Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 22: 281– 284, 1998 130O'Riordain MG, Fearon KC, Ross JA, et al: Glutamine-supplemented TPN enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 220: 212- 221, 1994 Citing Literature Volume24, Issue4July 2000Pages 197-209 ReferencesRelatedInformation
Referência(s)